Contact
| Email: | |
|---|---|
| Phone: | +420 54949 8144 |
| Research group: | Microenvironment of Immune Cells - Marek Mráz |
| Workplace: |
27. July 2021
Research team led by Marek Mraz published new findings on the interaction of drugs used in the treatment of chronic lymphocytic leukemia
New findings might help reduce the toxicity of the treatment and also its cost Press release; A team of scientists led by Assoc. Prof. Marek Mraz…
Publications that are part of the Web of Science database, possibly also other publications chosen by authors.
2021
- Sharma, S; Pavlasova, GM; Seda, V; Cerna, KA; Vojackova, E; Filip, D; Ondrisova, L; Sandova, V; Kostalova, L; Zeni, PF; Borsky, M; Oppelt, J; Liskova, K; Kren, L; Janikova, A; Pospisilova, S; Fernandes, SM; Shehata, M; Rassenti, LZ; Jaeger, U; Doubek, M; Davids, MS; Brown, JR; Mayer, J; Kipps, TJ; Mraz, M, 2021: miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors. BLOOD 137(18), p. 2481 - 2494, doi: 10.1182/blood.2020005627
2019
- Zaprazna, K; Reblova, K; Svobodova, V; Radova, L; Bystry, V; Baloun, J; Durechova, K; Tom, N; Loja, T; Buresova, M; Stranska, K; Oltova, A; Doubek, M; Atchison, ML; Trbusek, M; Malcikova, J; Pospisilova, S, 2019: Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia. ANNALS OF HEMATOLOGY 98(2), p. 423 - 435, doi: 10.1007/s00277-018-3520-5
2018
- Pavlasova, G; Borsky, M; Svobodova, V; Oppelt, J; Cerna, K; Novotna, J; Seda, V; Fojtova, M; Fajkus, J; Brychtova, Y; Doubek, M; Pospisilova, S; Mayer, J; Mraz, M, 2018: Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels. LEUKEMIA 32(9), p. 2028 - 2031, doi: 10.1038/s41375-018-0211-0
2017
- Pavlasova, G; Musilova, K; Seda, V; Cerna, K; Vojackova, E; Svobodova, V; Mraz, M, 2017: The identification of combinatorial therapeutic approaches with BCR inhibitors in B cell malignancies. MOLECULAR CANCER THERAPEUTICS 16(10)
- Pavlasova, G; Borsky, M; Svobodova, V; Musilova, K; Cerna, K; Seda, V; Osickova, J; Brychtova, Y; Doubek, M; Pospisilova, S; Mayer, J; Mraz, M, 2017: BCR SIGNALLING PROFICIENT CHRONIC LYMPHOCYTIC LEUKAEMIA B CELLS ARE PRONE TO RITUXIMAB MEDIATED ELIMINATION IN VIVO. HAEMATOLOGICA 102, p. 412 - 412